Next Article in Journal
Metabolomic Profiling and Biological Activities of Pleurotus columbinus Quél. Cultivated on Different Agri-Food Byproducts
Next Article in Special Issue
The Impact of Differences in Surveillance Definitions of Hospital Acquired Urinary Tract Infections (HAUTI)
Previous Article in Journal
Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow
Previous Article in Special Issue
An Outbreak of tet(X6)-Carrying Tigecycline-Resistant Acinetobacter baumannii Isolates with a New Capsular Type at a Hospital in Taiwan
Review

Infection Control in the Era of COVID-19: A Narrative Review

1
Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy
2
Department of Infectious Diseases, Cardinal Massaia, 14100 Asti, Italy
3
School of Medicine, Tufts University, Boston, MA 02111, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Maria Bagattini
Antibiotics 2021, 10(10), 1244; https://doi.org/10.3390/antibiotics10101244
Received: 7 September 2021 / Revised: 7 October 2021 / Accepted: 11 October 2021 / Published: 14 October 2021
COVID-19 quickly became a pandemic causing millions of infections and mortalities. It required real-time adjustments to healthcare systems and infection prevention and control (IPC) measures to limit the spread and protect healthcare providers and hospitalized patients. IPC guidelines were adopted and developed based on experience gained during the MERS-CoV and SARS-CoV outbreaks. The aim of this narrative review is to summarize current evidence on IPC in healthcare settings and patients with COVID-19 to prevent nosocomial infections during the actual pandemic. A search was run on PubMed using the terms (‘COVID-19’ [Mesh]) AND (‘Infection Control’ [Mesh]) between 2019 and 2021. We identified 86 studies that were in accordance with our aim and summarized them under certain themes as they related to COVID-19 infection control measures. All the guidelines recommend early diagnosis and rapid isolation of COVID-19 patients. The necessary precautions should be taken comprising the whole process, starting with an infectious disease plan, administrative and engineering controls, triage, and PPE training. Guidelines should target modes of transmission, droplet, aerosol, and oral–fecal, while recommending control precautions. Healthcare facilities must promptly implement a multidisciplinary defense system to combat the outbreak. View Full-Text
Keywords: infection control; COVID-19; healthcare-associated infection infection control; COVID-19; healthcare-associated infection
Show Figures

Figure 1

MDPI and ACS Style

Shbaklo, N.; Lupia, T.; De Rosa, F.G.; Corcione, S. Infection Control in the Era of COVID-19: A Narrative Review. Antibiotics 2021, 10, 1244. https://doi.org/10.3390/antibiotics10101244

AMA Style

Shbaklo N, Lupia T, De Rosa FG, Corcione S. Infection Control in the Era of COVID-19: A Narrative Review. Antibiotics. 2021; 10(10):1244. https://doi.org/10.3390/antibiotics10101244

Chicago/Turabian Style

Shbaklo, Nour, Tommaso Lupia, Francesco G. De Rosa, and Silvia Corcione. 2021. "Infection Control in the Era of COVID-19: A Narrative Review" Antibiotics 10, no. 10: 1244. https://doi.org/10.3390/antibiotics10101244

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop